William O. Tatum, IV, D.O.

Return to Top

Return to Top

Return to Top

1. Tatum WO, Coker SB, Ghobrial M, and Abd-Allah S.
   The open opercular sign: diagnosis and significance.
   Presented in abstract form at the American Academy of Neuroimaging, Orlando, Florida 1989.
   PMID:3242525
   
   
2. Tatum WO, Sperling MR, O'Connor MJ, and Jacobstein JG.
   Interictal SPECT in the presurgical evaluation of intractable partial epilepsy.
   (Presented in abstract form at the American Epilepsy Society Meeting, San Diego, November 1990.)
   Epilepsia 1990;31(5):p 670.
   PMID:7626820
   
   
3. Sperling MR, O'Connor MJ, Morrel MJ, Phillips CA, Bridgman PA, Tatum WO, and French JA.
   A noninvasive protocol for anterior temporal lobectomy.
   (Presented in abstract form at the American Epilepsy Society Meeting, San Diego, November 1990.)
   
   
4. Tatum WO, Stecker MM, Sperling MR, and French JA.
   SPECT clarifies the EEG in status epilepticus.
   (Presented in abstract form at the American Epilepsy Society Meeting, Philadelphia, PA, October 1991.)
   
   
5. Tatum WO, Chheda H, and Easton TS.
   SPECT during Suggestion of non-epileptic seizures.
   Presented in abstract form at the American Epilepsy Society Meeting. Miami, Florida, December 1993.
   
   
6. Tatum WO, Sperling MR, O’Connor MJ, Jacobstein JG.
   Interictal SPECT as a predictor of post-operative seizure relief in temporal lobe epilepsy.
   Presented in abstract form at the American Epilepsy Society Meeting, New Orleans, LA, December 1994.
   
   
7. Zachariah SB and Tatum WO.
   Gabapentin treatment of seizures in acute intermittent porphyria. Neurology 1995; 45(4):250.
   Presented in abstract form at American Academy of Neurology, 47th Meeting. Seattle, Washington.
   PMID:7783893
   
   
8. TATUM, WO.
   Klinefelter's syndrome and partial epilepsy.
   Presented in abstract form at the American Epilepsy Society Annual Meeting. Baltimore, Maryland. December 1995.
   
   
9. TATUM WO and Passaro EA.
   Epileptic amnestic dementia.
   Presented in abstract form at the American Epilepsy Society Annual Meeting. San Francisco, California. December 1996.
   
   
10. Liporace J, TATUM WO, Morris G, and French J.
    Clinical utility of sleep deprived versus computer assisted ambulatory 16 channel EEG in epilepsy patients: A multicenter study.
    Presented in abstract form at the American Epilepsy Society Annual Meeting. San Francisco, California. December 1996.
    
    
11. French JA, Williams S, Morris G, Tatum WO, and Privatera M.
    "Post-marketing Use of Topiramate"
    Presented in abstract form American Epilepsy Society Meeting in Boston, MA. December 1997. Epilepsia 1997;38(8):p 96.
    
    
12. Tatum IV WO,
    Seizure Recognition: Outpatient results with computer-assisted ambulatory in 16-channel EEG.
    Presented in abstract form at the American Epilepsy Society Meeting in Boston, MA December 1997.
    Epilepsia 1997;38(8):p 115.
    
    Tatum IV WO, French JA, Faught E, Williams S.
    Postmarketing experience with topiramate and cognition.
    Presented in abstract form at the American Epilepsy Society Meeting in San Diego, CA, December 1998.
    Epilepsia 1998;39(6):p 56.
    PMID:11580760
    
    
13. Carrazana EJ, DeToledo J, Tatum W et al.
    Epilepsy and Religious experiences: Voodoo possession.
    Presented in abstract form at the American Epilepsy Society Meeting in San Diego, CA, December 1998.
    Epilepsia 1998;39(6):p 226.
    
    
14. Benbadis S, Anthony K, Caines G, Hess G, Jackson C, Tatum WO, Ferreira J, Gieron-Korthals M.
    A prolonged and multi-modality technique for inducing pseudoseizures: preliminary results.
    To be presented in part at the American Epilepsy Society Meeting in Orlando, FL, December 1999
    
    
15. Carrazana EJ, Wheeler SD, Bolanos A, Tatum WO, Ferreira J, Ramirez-Mejia C.
    Gabapentin in the treatment of migraine headaches associated with benign sylvian spikes and benign childhood epilepsy.
    Presented in part at the American Epilepsy Society Meeting in Orlando, FL, December 1999.
    
    
16. Tatum IV WO, Ferriera JA, Benbadis SR, Vale FL.
    Vagus nerve stimulation and antiepileptic drug reduction.
    Presented in part at the American Epilepsy Society Meeting In Orlando, FL, December 1999.
    
    
17. Benbadis Sr, Agrawal V, Tatum WO IV
    How Many patients with psychogenic nonepileptic seizures also have epilepsy.
    Presented at the American Clinical Neurophysiology Society. September 2000. Montreal, Canada.
    
    
18. Vale F, Benbadis SR, Murtagh FR, Tatum WO
    MRI of the brain in patients with the vagus nerve stimulator.
    Presented at the American Epilepsy Society Meeting, December 2-7, 2000. Los Angeles, CA
    
    
19. Benbadis SR, Wallace J, Murtagh FR, Tatum WO, Vale F
    How common is unilateral MTS in subjects without seizures?
    Presented at the American Epilepsy Society Meeting, December 2-7, 2000. Los Angeles, CA
    
    
20. Tatum WO IV, Johnson K.
    Cost Analysis of Diazepam Rectal Gel Use in Institutionalized Epilepsy Patients
    Presented at the American Epilepsy Society Meeting, December 2-7, 2000. Los Angeles, CA
    
    
21. Harden C, French J, Fix A, Jacobsen W, Montouris G, Tatum WO, et al.
    Use Of Oxycarbazepine In Clinical Practice: Data From the PADs Group.
    Presented at the American Epilepsy Society Meeting, Los Angeles, CA . December 2-7, 2000.
    
    
22. Kanner A, Faught E, French J, Tatum W, et al.
    Psychiatric Adverse Events Caused by Topiramate and Lamotrigine: A Post Marketing Prevalence and Risk Factor Study
    Presented at the American Epilepsy Society Meeting, Los Angeles, CA . December 2-7, 2000
    
    
23. Benbadis S, Tatum WO, Gieron M and Ferreira, J.
    The Overinterpretation of EEGs: A Common Cause for the Misdiagnosis of Epilepsy?
    Presented at the American Epilepsy Society Meeting, Philadelphia, PA November 30 - December 5, 2001.
    
    
24. Tatum WO and Benbadis S.
    Patient Perception of Emergency Rectal Medications for Refractory Seizures.
    Presented at the American Epilepsy Society Meeting, Philadelphia, PA November 30 - December 5, 2001.
    
    
25. Brozman B, Tatum WO, Ferreira J, et al.
    Vagal Nerve Stimulation: Efficacy of Standard Versus Rapid Cycling.
    Presented at the American Epilepsy Society Meeting, Philadelphia, PA November 30 - December 5, 2001.
    
    
26. Vale, F, Tatum WO, Gieron M, et al.
    Results of Epilepsy Surgery at a Single Epilepsy Program.
    Presented at the American Epilepsy Society Meeting, Philadelphia, PA November 30 - December 5, 2001.
    
    
27. Williamson, DJ, PhD, Tatum WO, Loring DW, PhD.
    Wada We Doing with Wada? A survey of Current Practice Patterns.
    Presented at the American Epilepsy Society Meeting, Philadelphia, PA. November 30- December 5, 2002
    
    
28. Tatum WO, Ferreria JA, Benbadis SR, Rodgers-Neame, NT, Gieron M, Heriaud LS, and Vale FL.
    The Clinical Course of VNS End of Service.
    Presented at the American Epilepsy Society Meeting, Philadelphia, PA. November 30- December 5, 2002.
    
    
29. Tatum WO, Banbadis SR, Heriaud LS and Vale FL.
    Non-Lesional Temporal Lobectomy: Outcome and Concordance in Preoperative Assessment.
    Presented at the American Epilepsy Society Meeting, Boston, MA. December 2003.
    
    
30. Zesiewicz, TA, Sullivan KL, Maldonado JL, Tatum WO and Hauser, RA.
    Levetiracetam in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease.
    Presented at the 56th Annual Meeting of the American Academy of Neurology. 2003.
    
    
31. Recio MV, Malek A, and Tatum WO.
    Diffusion Weighted Imaging in Status Epilepticus during VNS.
    Presented at the 56th Annual Meeting of the American Academy of Neurology. 2003.
    
    
32. Selim R Benbadis, MD, Kristin Siegist, MD, William O Tatum, DO, Kip Anthony, REEGT, and Leanne Heriaud, RN.
    Short-Term Outpatient EEG-Video With Activation for the Diagnosis of Psychogenic Non-Epileptic Seizures.
    Submitted to be presented at the American Epilepsy Society Meeting, New Orleans, LA. 2004.
    
    
33. Tatum IV WO and Orth T.
    Case Management in Epilepsy: An Impact Study.
    Presented at the American Epilepsy Society Meeting, New Orleans, LA December 2004.
    
    
34. Vale FL, Packer EM, Lee D, Tatum WO and Benbadis SR.
    Temporal Lobectomy After 50.
    Presented at the American Epilepsy Society Meeting, New Orleans, LA. December 2004.
    
    
35. Leon YC, Sesta J, Tatum WO and Benbadis SR.
    Comparison of Rey-Osterrieth Figure Qualtative Errors on Recall Performance Between Right and Left Temporal Lobe Epilepsy Patients.
    Presented at the American Epilepsy Society Meeting, New Orleans, LA. December 2004.
    
    
36. Tatum IV WO and Orth T.
    Case Management in Epilepsy: An Impact Study.
    Epilepsia 2004, Volume 54, Supplement 7, page 87.
    
    
37. Tatum IV WO, Benbadis SR, Hussain A, Kaminiski B, Heriaud LS, and Vale
    FL Surgical Outcome: Temporal Lobe Epilepsy and Normal Brain MRI.
    Presented at the American Epilepsy Society Meeting. Washington, D.C. December 2005.
    
    
38. Vale FL, Tatum WO 4th, Benbadis SR.
    Results of Anterior Mesial Temporal Lobectomy for Intractable Epilepsy in Patients with Dual Radiographic Abnormalities.
    Presented at the American Epilepsy Society meeting. Washington D.C. December 2005.
    
    
39. Leon YC, Benbadis SR, Tatum WO 4th , Sesta J.
    Assessment of Anger in Patients with Epilepsy and Psychogenic Non-epileptic Seizures.
    To be presented at the American Academy of Neurology meeting 2005 (submitted).
    
    
40. Tatum WO IV, Anthony K, Heriaud L, Benbadis SR, Haber A, Vale FL. The Use of Intracranial Electrodes for Medically Intractable Epilepsy: A 6 year analysis. The American Epilepsy Society Meeting, San Diego, CA, December 2006 (accepted).
    
    
41. Justen EB, Catalano G, Tatum WO IV. The Psychiatric Profile of Patients with Psychogenic Non-epileptic Seizures (PNES). The American Epilepsy Society Meeting, San Diego, CA, December 2006 (accepted).
    
    
42. Tatum WO IV, Al-Saadi S, Benbadis SR, Heriaud L, Haber A, Vale FL. Intracranial electrode arrays do not predict outcome following epilepsy surgery. Presented in part at the American Clinical Neurophysiology Society meeting. Chicago, IL, November 2006.
    
    
43. Tatum WO IV, Al-Saadi S, Benbadis, Heriaud L, Haber A, Vale FL. Intracranial Electrodes: a 6 year experience. Presented in part at the American Epilepsy Society meeting, San Diego, CA 12/06.
    
    
44. Tatum WO IV, Benbadis SR, Haber A, Kelley V, Rodgers-Naeme T, Vale F. Epilepsy Surgery and the Disabled. Philadelphia, PA 2008 (to be presented).
    
    
45. Tatum WO IV, Ho S, Benbadis SR. A Hospital Based EEG Study of Refractory Idiopathic Generalized Epilepsy. American Clinical Neurophysiology Society Meeting. Savannah, GA 2/14/08.
    
    

Return to Top

1. Echiverri HD, Tatum WO, Merens TA, and Coker SB.
   Akinetic Mutism: Pharmacologic probe of the dopaminergic mesencephalofrontal activating system.
   Pediatric Neurology 1988; 4:228-230.
   PMID:3242525
   
   
2. Tatum WO, Coker SB, Ghobrial M, and Abd-Allah S.
   The open opercular sign: diagnosis and significance.
   Annals of Neurology 1989; 25:196-199.
   PMID:2919869
   
   
3. Tatum WO, Sperling MR, and Jacobstein JG.
   Epileptic palatal myoclonus.
   Neurology 1991; 41(8):1305-6.
   
   
4. Tatum WO.
   Reply to note on palatal myoclonus to the Editor.
   Neurology 1992; 42(5):1125-1126.
   
   
5. Tatum WO, and Gonzalez MA.
   Carbamazepine toxicity in an epileptic induced by clarithromycin.
   Hospital Pharmacy 1994; 29(1):45-46.
   
   
6. Tatum, WO.
   Reply to note on carbamazepine toxicity in an epileptic induced by clarithromycin.
   Hospital Pharmacy.
   
   
7. Tatum WO, Sperling MR, O'Connor MJ, and Jacobstein JG.
   Interictal SPECT in partial epilepsy: Accuracy in localization and prediction in outcome.
   J. of Neuroimaging. 1995;5(3):142-144.
   
   
8. Tatum WO, Alavi A, and Stecker MM.
   The utility of Tc-MHPAO SPECT in partial status epilepticus.
   Journal Nuclear Medicine 1994; 35:1087-1094.
   PMID:8014662
   
   
9. Tatum WO, and Stecker MM.
   Letter to the Editor.
   Epilepsia 36(2):214-5, 1995.
   In reference to; Handforth A, Cheng JT, Mandelkern MA, Treiman DM. Markedly increased mesiotemporal lobe metabolism in a case with PLEDs: further evidence that PLEDs are a manifestation of partial status epilepticus published in Epilepsia 1994;35:876-81.
   
   
10. Tatum WO and Zachariah SB.
    Gabapentin treatment of seizures in acute intermittent porphyria.
    Neurology 1995; 45:1216-1217.
    
    
11. Response published in Epilepsy Network News for Mini-Fellowship Alumni of IM4, No. 1, 1995.
    Regional Meeting Update for Non-Neurologist on Seizures.
    
    
12. Tatum WO, Passaro E, Elia M, Guerrini R, Gieron M, and Genton P.
    Seizures in Klinefelter's syndrome.
    Pediatric Neurology 1998;19 (4), 275-278:
    PMID:9830997
    
    
13. Liporace J, Tatum IV W, Morris III GL, French J.
    Clinical utility of sleep-deprived versus computer-assisted ambulatory 16-channel EEG in epilepsy patients: a multi-center study.
    Epilepsy Res 1998;32:357-362.
    
    
14. Tatum WO, Ross J, and Cole AJ.
    Epileptic Pseudodementia.
    Neurology 1998; 50: 1472-1475.
    PMID:9596011
    
    
15. Tatum WO, Ross J, Cole A.
    Epileptic Pseudodementia.
    Search on Epilepsy 1999.
    
    
16. Carranzana E, DeToledo J, Tatum WO, et al.
    Epilepsy and Religious Experiences: Voodoo Possession.
    Epilepsia 1999;40 (2):239-241.
    
    
17. Tatum WO, Moore D, Stecker M, Baltuch G, French J and Vale F.
    Ventricular asystole during vagus nerve stimulation for epilepsy in humans.
    Neurology 1999;52:1267-1269.
    PMID:10214755
    
    
18. Tatum WO.
    Response from the Author, Ventricular aystole during vagus nerve stimulation for epilepsy in humans.
    Neurology 2000; 54:776
    
    
19. Tatum WO, Moore D, Stecker M, Baltuch G, French J and Vale F.
    Ventricular asystole during vagus nerve stimulation for epilepsy in humans.
    Search on Epilepsy 2000;7(2):10-12.
    
    
20. Tatum WO, Galvez R, Benbadis S, and Carrazana E.
    Anti-epileptic Drugs: Into the New Millenium.
    Archives of Family Medicine 2000 Nov-Dec;9(10)1135-41
    
    
21. Tatum WO.
    Response from the Author, Ventricular aystole during vagus nerve stimulation for epilepsy in humans.
    Neurology 2000; 54:776
    
    
22. Tatum WO, Moore D, Stecker M, Baltuch G, French J and Vale F.
    Ventricular asystole during vagus nerve stimulation for epilepsy in humans.
    Search on Epilepsy 1999;52:1267-1269.
    
    
23. Benbadis SR, Tatum WO, Vale F, Murtagh FR.
    MRI-evidence of mesial temporal sclerosis in patients with psychogenic nonepileptic seizures.
    Neurology 2000; 55:1061
    
    
24. Benbadis SR, Tatum WO IV.
    Reply to article; Prevalence of nonconvulsive status epilepticus in the comatose patient.
    Neurology 2000. Nov 14;55(9):1421-3.
    PMID:11087805
    
    
25. Benbadis SR, Tatum WO IV, Vale F.
    Non-pharmacologic options for medically intractable epilepsy. When drugs don’t work: A proposed algorithm.
    Neurology 2000;55:1780-1784.
    
    
26. Tatum WO, Moore D, Stecker M, Baltuch G, French J and Vale F.
    Ventricular asystole during vagus nerve stimulation for epilepsy in humans.
    Search on Epilepsy. Vol 7. No 2, 2000. P10-13.
    
    
27. Tatum WO, Benbadis SR.
    Neurosurgical Treatment of Epilepsy.
    Archives of Family Medicine 2000; Nov-Dec;9(10):1142-7
    
    
28. Benbadis SR, Johnson K, Anthony K, Caines G, Hess G, Jackson C, Ferreira J, Gieron M, Vale F and Tatum WO IV.
    Induction of psychogenic nonepileptic seizures without placebo.
    Neurology 2000; 55:1904-1905
    PMID:11134393
    
    
29. French JA, Naritoku D, Ramsay RE, Tatum IV WO.
    Dialogues in Neurotherapeutics: Best Practices in Epilepsy. 2001; 1(2):1-13.
    
    
30. Tatum WO, Johnson KD, Goff S, Ferreira J, Benbadis SR and Vale, F.
    Vagus Nerve Stimulation and Drug Reduction Neurology 2001;56:561-563.
    PMID:11261422
    
    
31. Carranza E and Tatum WO.
    Ictal Alien Hand Syndrome
    Epilepsy and Behavior 2001;(2),61-64.
    
    
32. Tatum, WO.
    Response to Letter to the Editor, Vagus Nerve Stimulation and Drug Reduction Neurology 2001;56:561-563.
    
    
33. Tatum WO, Winters L, Gieron MD, Passaro EA, Benbadis S, Ferreira J and Liporace J.
    Outpatient Seizure Identification: Results of 502 Patients Using Computer-Assisted Ambulatory EEG.
    Journal of Clinical Neurophysiology 2001;18(1):14-19.
    PMID:11290934
    
    
34. Benbadis SR and Tatum WO.
    Advances in the Treatment of Epilepsy.
    American Family Physician published by the American Academy of Family Physicians. 2001;(64),91-8,105-6.
    PMID:11456438
    
    
35. Tatum WO.
    Long-Term EEG Monitoring: A Clinical Approach to Electrophysiology.
    Journal of Clinical Neurophysiology 2001 Sep;18(5):442-455.
    PMID:11709650
    
    
36. Tatum WO, French JA, Benbadis SR and Kaplan PW.
    The Etiology and Diagnosis of Status Epilepticus.
    Epilepsy and Behavior 2001; 2:311-317.
    
    
37. Benbadis S, Vale F, Murtagh FR, Tatum WO, et al.
    MRI of the brain in patients with the vagus nerve stimulator. Seizure, in press.
    PMID:11749109
    
    
38. Benbadis SR, Agrawal V, Tatum WO IV.
    How many patients with psychogenic nonepileptic seizures also have epilepsy?
    Neurology 2001; 57:915-7.
    PMID:11552032
    
    
39. Tatum WO, French JA, Faught E, Morris III GL, Winters L, Fix A and the PADS investigators. Post Marketing Experience with Topiramate and Cognition. Epilepsia 2001; 42:1134-40.
    
    
40. Tatum IV WO, Liporace J, Benbadis SR and Kaplan PW. The Treatment of Women in Epilepsy. 2002. Accepted for publication in the Archives of Family Medicine 2002.
    
    
41. Tatum WO. Adult Perceptions of Emergency Rectal Medications for Refractory Seizures
    Epilepsy and Behavior 2002; 3(6):535-538.
    
    
42. Benbadis SR, Heriaud L, Tatum WO and Vale F.
    Epilepsy Surgery, Delays and Referral Patterns - Are All Your Patients Controlled?
    Seizure 2003. Apr;12(3):167-70.
    PMID:12651083
    
    
43. Benbadis SR and Tatum WO.
    Overinterpretation of EEGs and Misdiagnosis of Epilepsy
    Journal of Clinical Neurophysiology 2003. 20 (1):42-44.
    PMID:12684557
    
    
44. Tatum IV WO, Ferreira JA, Benbadis SR, Heriaud LS, Gieron M, Rodgers-Neame NJ and Vale F.
    Vagus Nerve Stimulation for Pharmacoresistant Epilepsy: Clinical Symptoms with End of Service.
    Epilepsy & Behavior, Volume 5, Issue 1, February 2004, Pages 128-132
    PMID:14751218
    
    
45. Tatum WO. Long-Term EEG Monitoring: A Clinical Approach to Electrophysiology.
    American Journal of Electroneurodiagnostic Technology. 43:74-97, 2003.
    
    
46. Kanner AS, Wuu J, Faught E, Tatum WO, et al.
    A Past Psychiatric History May Be A Risk Factor for Topiramate-Related Psychiatric and Cognitive Adverse Events.
    Epilepsy and Behavior 2003 (in press)
    
    
47. Benbadis SR, Tatum WO. and Gieron M
    Idiopathic Generalized Epilepsy and Choice of Anti-Epileptic Drugs.
    Neurology 2003;61:1793:1795.
    PMID:14694051
    
    
48. Tatum IV WO and Benbadis SR.
    Response to Letter to the Editor, Vagus nerve stimulation end of service.
    Epilepsy and Behavior 5 (2004) 612-615.
    
    
49. Benbadis SR, O’Neill E, Tatum IV WO and Heriaund L.
    Outcome of Prolonged EEG-Video Monitoring at a Typical Referral Epilepsy Center.
    Epilepsia 2004 Sep 45(9):1150-3.
    PMID:15329081
    
    
50. Mackie B., Murtagh R and Tatum W.
    Bilateral Parieto-occipital Polymicrogyria Diagnosed by MRI: A Case Report 2004.
    Submitted for publication.
    
    
51. Benbadis SR, Siegrist K, Tatum WO, Heriaund L and Anthony, K.
    Short-term outpatient EEG video with induction int he diagnosis of psychogenic seizures.
    Neurology 2004;63:1728-1730.
    PMID:15534269
    
    
52. Tatum WO, Malek A, Recio M, Orlowski J and Murtagh R.
    Diffusion weighted imaged and status epilepticus during vagal nerve stimulation.
    Epilepsy and Behavior 5 (2004) 411-415.
    PMID:15145313
    
    
53. Kanner AM, Wu J, Faught E, Tatum WO, Fix A, French JA, et al.
    A Past Psychiatric History may be a Risk Factor for Topiramate-Related Psychiatric and Cognitive Adverse Events.
    Epilepsy and Behavior. In Press, 2005.
    PMID:14527497
    
    
54. Sachdeo RC, Gates JR, Bazil CW, Barkley GL, Tatum WO IV, D’Souza JD, McCague K.
    Improved Quality of Life in Patients with Partial Seizures After Conversion to Oxcarbazepine Monotherapy.
    Epilepsy & Behavior 2005 (submitted).
    
    
55. Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA.
    Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    PMID:15954135
    
    
56. Tatum WO IV, Husain A, Benbadis SR, Kaplan PW.
    Normal Human Adult EEG and Normal Variants.
    J Clin Neurophysiol 2006;23(3):194-207.
    
    
57. Tatum WO IV.
    The Use of Antiepileptic Drugs in Pregnancy.
    Expert Review of Neurotherapeutics 2006;6(7):1077-1086.
    
    
58. Tatum WO IV.
    AOA Needs to Reach Out More.
    Letter to the editor. JAOA 2006 (in press).
    
    
59. Tatum WO IV, Benbadis SR, Hussain A, Kaminski B, Heriaud L, Al-Saadi S, Vale, FL.
    Ictal EEG Remains The Prominent Predictor Of Seizure Free Outcome After Temporal Lobectomy In Epileptic Patients With Normal Brain MRI.
    Epilepsia (submitted).
    
    
60. Tatum WO IV.
    Editorial Review on “In utero antiepileptic drug exposure: Fetal death and malformations by Meador KJ, Baker GA, Finnell RH et al.
    In Neurology 2006;67(3):407-12 (in press).
    
    
61. Tatum WO IV.
    AOA Needs to Reach Out More. Letter to the editor.
    JAOA 2006;106(8):442-3.
    
    
62. Tatum WO IV, Benbadis SR, Hussain A, Kaminski B, Heriaud L, Al-Saadi S, Vale, FL.
    Ictal EEG Remains The Prominent Predictor Of Seizure Free Outcome After Temporal Lobectomy In Epileptic Patients With Normal Brain MRI.
    Epilepsy & Behav 2006 (submitted).
    
    
63. Tatum WO IV.
    Editorial Review on “In utero antiepileptic drug exposure: Fetal death and malformations by Meador KJ, Baker GA, Finnell RH et al.
    In Neurology 2006;67(3):407-12. (in press).
    
    
64. Tatum WO IV, Al-Saadi S, Orth T.
    Case management improves outpatient epilepsy care.
    Neurology 2006 (submitted).
    
    
65. Pugh MJ V, Berlowitz DR, Montouris G et al (Tatum WO IV).
    What constitutes high quality of care for epilepsy?
    Neurology 2006 (submitted).
    
    

Return to Top

1. Tatum WO.
   Epilepsy.
   In: Neurology Pearls of Wisdom.
   Labanowski MJ, editor.
   Boston Medical Publishing, Inc., 1998; 205-218.
   
   
2. Tatum WO. Epilepsy.
   In: Neurology Pearls of Wisdom, 2nd Edition.
   Labanowski MJ, editor.
   Boston Medical Publishing, Inc., 2001. In press.
   
   
3. Tatum WO, Genton P, Bureau M, Dravet C and Roger J.
   Infrequent Epilepsy Syndromes
   The Treatment of Epilepsy, Practice and Principals 3rd Edition, Chapter 35.
   Elaine Wyllie MD, Editor,
   Baltimore, Williams and Wilkins 2001, p 551-575.
   
   
4. Associate Editor, CME Newsletter, Dialogues in Neurotherapeutics: Best Practices in Epilepsy.
   Sponsored by the University of Kentucky College of Medicine and Health Learning Systems.
   Health Learning Systems, Wayne NJ. 2001.
   
   
5. Tatum WO, Farrell K.
   Atypical Absence, Myoclonic, Tonic, and Atonic Seizures.
   The Treatment of Epilepsy: Principles & Practice, 4th edition. Chapter 21. In Wyllie E, ed. Lippincott, 2005 (in press).
   
   
6. Farrell K, Tatum WO.
   Encephalopathic Generalized Epilepsy and Lennox-Gastaut Syndrome.
   The Treatment of Epilepsy: Principles & Practice, 4th edition. Chapter 33. In Wyllie E, ed. Lippincott, 2005 (in press).
7. The Handbook of EEG Interpretation. In Tatum WO, Husain A, Benbadis SR, Kaplan PW, eds.
   Demos Publishers, 2008:1-276.
   
8. Tatum WO.
   Electrocorticography and Cortical Stimulation for Functional Brain Mapping.
   In Neuro-intraoperative Monitoring. Husain A, ed. Demos Publishers. 2007 (in press).

Return to Top

• Felbamate - Carter Wallace, Inc. Princeton, New Jersey.
  "An Open Label, Follow-Up, Long term Felbamate Therapy in Adult Subjects with Epilepsy."
  September 1990.
  
  
• Vigabatrin - Marion Merrell Dow, Inc. Cincinnati, Ohio.
  "Double Blind, Randomized, Placebo-Controlled, Parallel Group Study of Vigabatrin in Patients with Uncontrolled Complex Partial Seizures."
  September 1990.
  
  
• Topiramate - R. W. Johnson Pharmaceutical and Research Institute
  "Open Extension Protocol: Long Term Treatment with Topiramate"
  January 1988.
  
  
• Compassionate Use of Felbamate in Patients with Epilepsy, Protocol 242C.
  January 1993.
  Principal Investigator.
  Institution: Tampa General Hospital, Florida
  
  
• A Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Two Dose Levels (10 mg. and 20 mg.) of Intranasal Sumatriptan in the Acute Treatment of a Migraine Attack
  (Glaxo Pharmaceuticals, 1993).
  Co-Investigator.
  
  
• A Protocol to Provide Lamictal (Lamotrigine) for the Treatment of Serious or Life-Threatening Epilepsy, Protocol 26.
  May 1993.
  Principal Investigator.
  Institution: Tampa General Hospital, Tampa, Florida.
  
  
• Landmark Investigation of Felbamate in Epilepsy (L.I.F.E.) A 7-Week Open Label Replacement Therapy Protocol in Patients with Partial Epilepsy.
  January 1994.
  
  
• Vigabatrin - Marion Merrell Dow, Inc. Kansas City, Missouri,
  "Clinical Experience and Use of Sabril® in Patients with Partial Seizures."
  Protocol VGPR0098.
  June 1994.
  Principal Investigator.
  Site: Tampa General Hospital, Tampa, Florida.
  
  
• Clinical Evaluation of Extended-Release Oral Physostigmine in the Treatment of Patients with Dementia of the Alzheimer's Type (PR 1028).
  Forest Laboratories.
  November 1994.
  Co-Investigator.
  
  
• A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effectiveness and Safety of Migramist?(Dihydroergotamine Mesylate Nasal Spray) 2 mg for the Acute Treatment of Migraine Headache with or without Aura in Migraineur Families.
  Sandoz Pharmaceuticals.
  February 1995.
  Co-Investigator.
  
  
• A Trial of Recombinant Methionyl Human Brain-Derived Neurotrophic Factor (r-metHuBDNF) Given by Daily Subcutaneous Injection to Patients with Amyotrophic Lateral Sclerosis (ALS).
  Amgen-Regeneron Partners.
  Protocol 930121.
  Sub-investigator.
  
  
• An Active Treatment Safety Study of Recombinant Methionyl Human Brain-Derived Neurotrophic Factor (r-metHuBDNF) Given by Daily Subcutaneous Injection to Patients with Amyotrophic Lateral Sclerosis (ALS).
  Amgen-Regeneron Partners.
  Protocol 960116.
  Sub-investigator.
  
  
• A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III Study of the Safety and Efficacy of Intravenous Activase® Alteplase, Recombinant (Recombinant Tissue Plasminogen Activator, rt-PA) within 3-5 Hours of Onset of Acute Ischemic Stroke.
  Genentech, Inc.
  Protocol A0276g.
  Sub-investigator.
  
  
• An Open-Label, Multicenter Clinical Trial Evaluating the Safety and Efficacy of Donepezil Hydrochloride (E2020) in Patients with Alzheimer's Disease.
  Eisai America, Inc.
  Protocol E2020-A001-313.
  Sub-investigator.
  
  
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Impact of Sumatriptan Injection on Workplace Productivity Loss Due to Migraine.
  Glaxo Wellcome, Inc.
  Protocol SUMA4015.
  Sub-investigator.
  
  
• A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Tolerability of Four Doses of Oral Naratriptan in the Acute Treatment of a Single Migraine Attack.
  Glaxo Pharmaceuticals.
  Protocol S2WA3001.
  Sub-investigator.
  
  
• A Randomized, Double-Blind, Placebo-Controlled Crossover Study to Evaluate the Safety and Efficacy of Oral Naratriptan in the Acute Treatment of Four Migraine Attacks.
  Glaxo Pharmaceuticals.
  Protocol S2WA3003.
  Sub-investigator.
  
  
• A Phase II-III Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Two Doses of Intravenous Aptiganel Hydrochloride versus Placebo in Patients with an Acute Ischemic Stroke.
  Boehringer Ingelheim Pharmaceuticals, Inc.
  Protocol 534.11.
  Sub-Investigator.
  
  
• An Open, Randomized, Multicenter Study to Assess the Efficacy and Safety of 1.25 mg. QD and 10 mg. QD Zydis Selegiline in the Control of Symptoms of Parkinson's Disease in Patients Stabilized on a Regimen Including Selegiline.
  Scherer DDS.
  Protocol Z/SEL/95/008.
  Sub-Investigator.
  
  
• An Open, Multicenter Parallel Group Continuation Study to Assess the Safety of 1.25 mg Q.D. and 10 mg Q.D. Zydis Selegiline in The Control of Symptoms of Parkinson's Disease in Patients Stabilized on a Regimen Including Selegiline.
  Scherer DDS/Harris Clinical Research.
  Protocol Z/SEL/95/008 Extension.
  Sub-Investigator.
  
  
• A Multicenter, Double-blind, Randomized Comparison of Zolmitriptan and Sumatriptan in the Acute Treatment of Multiple Migraine Headaches.
  Zeneca.
  Protocol 311C90.
  Sub-Investigator
  
  
• A Double-Blind Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of a Second Sumatriptan Succinate Tablet (25 or 50 mg) in the Acute Treatment of Migraine.
  Glaxo Wellcome, Inc.
  Protocol SUMA 4014.
  Sub-Investigator
  
  
• A Treatment Protocol Using Myotrophin (human mecasermin [recombinant DNA origin])Injection in Patients With Amyotrophic Lateral Sclerosis.
  Cephalon, Inc
  Protocol C0151a/500/AL/US (version 1,3).
  Sub-Investigator
  
  
• A 26-week Prospective, Multi-Center, Open Label, Randomized Study to Compare Metrifonate and Standard Care. Patients With Dementia of the Alzheimer's Type of Mild to Moderate Severity Will Be Assigned to One of Two Treatment Arms (Metrifonate or Standard Care; 4:1 randomization.)
  Bayer Pharmaceutical M.I.N.T. Bay a 9826.
  Sub-Investigator
  
  
• A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Multicenter Trial of Two Doses of Fiblast (Trafermin) in Patients with Acute Stroke. Wyeth-Ayerst Research.
  Protocol 03062K1-200-US
  Sub-Investigator
  
  
• A Randomized Double-Blind, Parallel Group Study to Compare the Safety and Efficacy of Zydis Selegiline 1.25 to 2.5 mg q.d. with Placebo as an Adjunct in the Management of Parkinsonian Patients Being Treated with Levodopa Who Exhibit Deterioration in the Quality of Their Response to This Therapy.
  Scherer DDS/MDS Harris.
  Protocol #z/SEL/97/026.
  Sub-Investigator
  
  
• Clinical Experience and use of Sabril (Vigabatrin) in Patients With Partial Seizures.
  Hoechst Marion Roussel, Inc.
  Protocol Number VGPR0098.
  Clinical Phase IIIb Principal Investigator.
  
  
• A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Stratified, Parallel-Group Trial of Rufinamide as Adjunctive Therapy in Children and Adults With Inadequately Controlled Partial Seizures.
  Novartis.
  Phase III -Final Clinical Trial Protocol #3310101021 CGP33101 (rufinamide).
  Principal Investigator
  
  
• A Multicenter, Open-Label Trial of Lamotrigene in the treatment of Juvenile Myoclonic Epilepsy.
  Glaxo
  Phase IV Clinical Trial Protocol.
  Principal Investigator.
  
  
• Safety and Therapeutic Effect of Oxcarbazepine in Patients with Partial Seizures (STOPS).
  Novartis Pharmaceuticals
  Phase III
  Protocol No. CTR1476 US01.
  Principal Investigator
  
  
• Phase IV Open-Label, Multi-Center Community Based Trial Studying the Safety and Efficacy of Levetiracetam as Add-on Therapy in Adult Patients with Treatment-Resistant, Partial-Onset Epilepsy
  UCB Pharma, Inc.
  Protocol Number RPCE00A1201
  Principal Investigator.
  
  
• An Open-Label, Multicenter study to Assess the Safety and Effectiveness of Diastat ® (diazepam rectal gel) in the Treatment of Seizures in Adults.
  Elan Pharmaceuticals, Inc.
  Phase IV.
  Protocol number AN094-502.
  Principal Investigator
  
  
• A Multi-Center, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial of the Efficacy and Safety of Three Doses of Harkroseride as Add-On Therapy in Patients with Partial Seizures with and without Secondary Generalization. Phase IIA.
  Schwartz Pharma.
  Principal Investigator.
  
  
• A Multi-Center, Open-Label Study to demonstrate the equivalence of twice daily dosing of Reminyl compared to once daily dosing of Vitamin E in regard to compliance and to determine caregiver and physician satisfaction with Reminyl in the treatment of patients with Alzheimer’s disease using the Reminyl Satisfaction Questionnaire. Phase IV.
  Sponsored by Janssen Pharmaceutica, Inc.
  Protocol number GAL-USA-23.
  Principal Investigator.
  
  
• Efficacy and Safety of Talampanel as Adjunctive Therapy in Patients with Partial Seizures: A Phase II Clinical Trial.
  Protocol IXL-201-14-189.
  Sponsored by Ivax Pharmacueticals.
  Principal Investigator.
  
  
• Collection of Digital EEG Data from Patients with Epilepsy Undergoing Video EEG Telemetry.
  Protocol # BNC0502 Revision C. Version date: 3/9/06.
  Sponsored by BioNeuronics Corporation.
  Subinvestigator.
  

Return to Top

• 1992 Region IV & VI, Epilepsy Conference
  Radisson Bay Harbor Inn, Tampa, Florida.
  April 24 - 26, 1992.
  
  
• St. Joseph's Neuroscience Institute
  Long Term Seizure Monitoring Units
  Tampa, Florida
  June 23, 1992
  
  
• First Southeastern Neuroscience Nursing Symposium
  St. Joseph's Medical Arts Building, Tampa, Florida.
  September 26, 1992.
  
  
• Epilepsy Update: Medical and Surgical Management for the Adult and Pediatric Neurologist
  Wyndham Harbour Island Hotel, Tampa, Florida.
  March 20, 1993.
  
  
• "Treatment Dilemmas."
  Co-Sponsored CME Programs through Abbott Labs.
  Speakers included R. Eugene Ramsey on Evaluation of Patients with Primary versus Secondary Epilepsy.
  April 14, 1993.
  
  
• Symposium "Timely Topics in Medicine." Lecture "Current Diagnosis and Treatment of Epilepsy."
  St. Joseph's Hospital.
  November 5-6, 1993.
  
  
• "Epilepsy Update: Controversies and Consensus in Epilepsy Management for the Adult and Pediatric Neurologist." Lecture "Intractable Epilepsy."
  Speakers included Dudley Dinner, M.D., Maria Gieron-Korthals, M.D., Thomas Brown, M.D., Mark Yerbe, M.D., Hemant Chheda, M.D. and Seema Eichler, PhD.
  Wyndham Harbour Island Hotel, Tampa, Florida.
  March 12, 1994.
  
  
• Symposium "Management of Seizures for the Non-Neurologist for Family Practitioners." Course Director. Lecture "Managing Persistent Seizures."
  CME Accredited.
  Speakers included R. Eugene Ramsey, B.J. Wilder and Erasmo Passaro.
  Tampa General Hospital.
  November 18, 1995.
  
  
• Southern Clinical Neurology Society Meeting.
  Chairman, Dr. B.J. Wilder and speakers including Robin Gilmore, Basim Uthman, Kimford Meador, Joseph Bruni, Ira Goodman and Kenneth Heilman.
  Lectures included Presurgical Assessment/Medical Intractability in Epilepsy Patients and also the New Antiepileptic Drugs.
  Mission Inn, Howie-in-the-Hills, Florida.
  April 19-21, 1996.
  
  
• Neurotransmitter Update-1996, "New Antiepileptic Drugs."
  CME Accredited.
  Memorial Hospital Jacksonville.
  September 14, 1996.
  
  
• "Advances in the Therapy of Seizure Disorders."
  CME Accredited.
  Florida Osteopathic Medical Association Midyear Seminar.
  Wyndham Harbour Island Hotel.
  September 20-22, 1996.
  
  
• Symposium "Post Traumatic Seizures: New Directions in the Treatment of Epilepsy."
  Speakers included Jerome Engel, James Riviello, Jane Boggs, Erasmo Passaro, and Jackie French.
  St. Petersburg Beach, Florida.
  October 19, 1996.
  
  
• Second Annual Mission Inn Family Neurological Update."Post Traumatic Seizures."
  Sponsored by: Southern Clinical Neurological Society. (B.J. Wilder, M.D. University of Florida).
  April 25-27, 1997.
  
  
• "Clinical Manifestation of Seizures and Epilepsy in Mentally Retarded/Multiple Handicapped."
  Mid-Florida Network of The Developmental Disabilities Nurses Association.
  Tampa, Florida.
  September 11, 1997.
  
  
• "Practical Issues In Epilepsy Management"
  Course Director, One-Day Symposium at Busch Gardens, Tampa, Florida.
  November 8, 1997 ( with R. Eugene Ramsay M.D., University of Miami)
  
  
• Lecturer, "AEDS: What to Use and How" and "Non-Medical Treatment of Seizures".
  The International Center for Epilepsy, University of Miami. Dr. Eugene Ramsay, Course Director.
  Tarpon Springs, Florida.
  June 27, 1998.
  
  
• Symposium "AEDs: Past, Present and Future" University of Florida "War on Seizures".
  Lecturer. Robin Gilmore, Course Director.
  Gainesville, Florida.
  October 19,1998.
  
  
• Neurology Grand Rounds "Neurologic Applications of AEDs".
  Allegheny University (Hahneman).
  Philadelphia, PA.
  October 16, 1998.
  
  
• Critical Issues in the Use of Antiepileptic Drugs (AEDs)
  Sponsored by the Southern Clinical Neurological Society. Dr. BJ Wilder course director.
  Hyatt Regency, Tampa City Center, Tampa, FL.
  September 11, 1999
  
  
• Case Specific Epilepsy Management: A Case Study Roundtable.
  Sponsored by the Glaxo and the Thomas R. Beam Jr. Memorial Institute for Continuing Medical Education.
  Del Frisco’s. Orlando, FL
  November 30, 1999
  
  
• Acute Seizure Management and Status Epilepticus.
  Clinicon Conference for EMS Providers.
  Sponsored by the Florida Emergency Medical Foundation.
  Orlando, Florida.
  July 15, 2000
  
  
• Neurology Consultant’s Conference.
  Health Learning Systems.
  Fairmont Hotel, Chicago, IL
  August 11, 2000
  
  
• Pharmacy Review on Antiepileptic Drugs (AEDs).
  Lecture given to pharmacists for Hillsborough County Pharmacy Association.
  Sponsored by Parke Davis/Pzifer Pharmaceuticals.
  Tampa, FL
  August 24, 2000.
  
  
• Dialogues in Neurotherapeutics Roundtable: Best Practices in Epilepsy.
  Health Learning Systems.
  Four Seasons Hotel, Philadelphia, PA.
  September 28, 2000
  
  
• Recognizing Status Epilepticus.
  St. Joseph’s Hospital 2nd Annual Epilepsy Seminar.
  Clearwater Beach, FL
  September 29-30, 2000
  
  
• Seizures and Epilepsy: An Introduction. “Neurology for the Non-Neurologist”.
  Sponsored by the Bays Medical Society.
  Panama City, FL
  October 20, 2000.
  
  
• Preventing Seizures: Clinical and Personal Strategies. “Putting Prevention into Practice”.
  Sponsored by the Florida Department of Health.
  St. Petersburg, FL
  October 23, 2000.
  
  
• New Anti-Epileptic Drugs into the New Millennium.
  Neurology Grand Rounds.
  Bayfront Medical Center, St. Petersburg, Florida.
  Sponsored by Glaxo-Wellcome.
  1 hour CME.
  January 8, 2001.
  
  
• Seize the Moment - Diagnosis and Treatment of Status
  Neurological Update 2001.
  Sponsored by the University of Miami School of Medicine. Miami, FL.
  January 31-February 3, 2001
  
  
• Vagus Nerve Stimulation.
  26th Annual Seminars in Family Practice.
  Sponsored by the Southwest Florida Osteopathic Medical Society.
  Sanibel Island, Florida.
  October 25-28, 2001.
  
  
• The Rising Challenge of Peripheral Neuropathy.
  85th Annual Family Practice Weekend.
  Sponsored by the Florida Academy of Family Physicians.
  Renaissance Vinoy Resort and Golf Club. St. Petersburg, Florida.
  November 30 - December 2, 2001.
  
  
• Vagus Nerve Stimulation.
  North Carolina Neurological Society Annual Meeting Charlotte, North Carolina.
  October 19, 2002
  
• Normal Adult EEG and normal variants.
  Lecturer at the Annual Course of the ACNS. American Clinical Neurophysiology Society Meeting.
  2005.
• Funny Looking Normal EEG.
  Lecuter at the Annual Course of the ACNS.
  American Clinical Neurophysiology Society Meeting.
  Chicago, IL 11/1/06.
• South Society of EEG Technology. Seizures and Pseudoseizures.
  Lecturer.
  Jacksonville, Florida 11/15/06.
• Osler Review Course.
  Lecturer: Updates on Epilepsy.
  Quarum Hotel, Tampa Florida. 3/17/07.
• Florida Annual Physician’s Assistant Meeting. Tampa, Florida.
  Lecturer: Seizures and Pseudoseizures. 6/20/07.
• American Society of Electrodiagnostic Technologists, Inc. (ASET) Annual Conference.
  Lecturer: The Electroclinical Spectrum of Epilepsy.
  Orlando Florida 7/20/07.
• American Academy of Neurology Annual Meeting, Boston MA 5/4/07; Full-Day Course 7FC.006 Clinical Epilepsy.
  Lecturer, “Seizures, Pseudoseizures, and Pseudopseudoseizures”.
• Grand Rounds; Department of Neurology and Psychiatry @ University of Toledo (Ohio) College of Medicine.
  Invited Lecturer: Seizures, Pseudoseizures, and Pseudopseudoseizures. 9/20/07.

Return to Top

• Conference Co-Chairman.
  "So Someone You Know Has Epilepsy."
  Tampa General Hospital Conference.
  November 2, 1993.
  
  
• Co-moderator for Landmark Investigation of Felbamate in Epilepsy
  (L.I.F.E.) Clinician Investigators Workshop.
  Hyatt Regency Hotel, Tampa, Florida.
  January 19, 1994
  
  
• Hillsborough County Health Department
  Updates in Epilepsy.
  March 18, 1994.
  
  
• Symposium "So Someone You Know Has Epilepsy," (Epilepsy Education for Lay Population).
  Lecture "Understanding Epilepsy."
  Tampa General Hospital.
  November 2, 1994.
  
  
• "Antiepileptic Drugs and the Physically and Mentally Handicapped."
  Sponsored by Parke-Davis.
  Donatello's Restaurant.
  August 12, 1995.
  
  
• Symposium "Mastering the Treatment of Epilepsy."
  Course Director.
  Lectures "Diagnosis and Classification of Epilepsy," "New AEDs and Polypharmacy" and "Status Epilepticus."
  Clearwater, Florida.
  October 7-8, 1995.
  
  
• "Differential Diagnosis of Seizures for Family Practitioners." Sponsored by Marion Merrell Dow. Schula's Restaurant. October 26, 1995.
  
  
• Symposium "So Someone You Know Has Epilepsy." (Lay Population Epilepsy Conference.) Lectures "What is a Seizure" and "When Drugs Don't Work."
  Tampa General Hospital. November 3, 1995.
  PMID:11188984
  
  
• "New Antiepileptic Drugs and Treatment in the Elderly."
  Grand Rounds, Bayfront Medical Center.
  February 1996.
  
  
• "New Antiepileptic Drugs."
  Suncoast Medical Clinic.
  May 12, 1996.
  
  
• "New Advances in the Treatment of Epilepsy: Focus on Lamotrigine."
  Sponsored by Cerenex Pharmaceuticals.
  Donatello's Restaurant.
  May 21, 1996.
  
  
• "New Frontiers of AED Treatments."
  Dinner lecture at Harry's Continental Kitchen, Long Boat Key, Florida.
  October 30, 1996.
  
  
• Round Table Discussion on Treatment Strategies of Epilepsy. Case Review.
  St. Petersburg Medical Clinic, St. Petersburg, Florida.
  November 5, 1996.
  
  
• "Expanding the Therapeutic Options in Epilepsy Patient Care"
  Dinner Lecture Regarding "New Antiepileptic Drugs".
  Dinner at Smitty's, Fort Myers, Florida.
  May 27, 1997.
  
  
• "Expanding the Therapeutic Options in Epilepsy Patient Care"
  Dinner Lecture at Andrew's North, Tallahassee.
  July 23, 1997.
  
  
• "New Antiepileptic Drugs"
  Lecture given at Epilepsy Services of West Central Florida.
  July 25, 1997.
  
  
• "Treatment of Epilepsy in Mentally-Retarded/Multiple Handicapped".
  Donatello's Dinner Lecture.
  November 19, 1997.
  
  
• "New AEDS".
  Winter Park Memorial Hospital, Winter Park, Florida.
  December 3, 1997.
  
  
• Lecturer, Round Table Discussion of New AEDs. Neurology Group.
  Clearwater, Florida.
  February 24, 1998.
  
  
• Lecturer, Lamotrigene Monotherapy.
  Neurology Advisory Panel Meeting. Tampa Bay Neurologists.
  Donatello's Restaurant. Tampa, Florida.
  Spetember 28, 1998.
  
  
• Lecturer, Topiramate: Emerging Applications.
  Clearwater Neurology Associates. Clearwater, Florida.
  October 1, 1998.
  
  
• Lecturer, Video EEG Monitoring.
  University Community Hospital. Tampa, Florida.
  October 27, 1998.
  
  
• Lecturer, "Toward a Life Without Seizures".
  Epicon 1998 Conference.
  Epilepsy Foundation of Southwest Florida.
  Sarasota, Florida.
  November 7, 1998.
  
  
• Lecturer, Round Table Discussion/Case Presentation using Lamotrigene.
  Largo Diagnostic Center. Largo, Florida.
  March 4, 1998.
  
  
• Lecturer, "New Antiepileptic Drugs". Case Reports Discussion.
  Clearwater Neurological Associates. Clearwater, Florida.
  February 24, 1998.
  
  
• Lecturer, "Epilepsy and multiple handicap".
  American Association of Retarded Persons (Nurses). Tampa, Florida.
  February 26, 1998.
  
  
• Lecturer, "New Antiepileptic Drugs". Case Reports Discussion.
  Largo Diagnostic Medical Center Neurology. Largo, Florida.
  March 4, 1998.
  
  
• Lecturer, Update on Lamotrigene.
  Neurology Advisory Meeting. Tampa Bay Neurologists.
  May 6, 1998.
  
  
• Lecturer, "New Antiepileptic Drugs"
  Sarasota Neurologists. Sarasota, Florida.
  May 20, 1998.
  
  
• Lecturer, "New Therapy in Epilepsy Management".
  St. Petersburg, Florida.
  May 28, 1998.
  
  
• Lecturer, Vagus Nerve Stimulation.
  Tampa Bay Neurologists. Shula's Restaurant, Tampa, Florida.
  July 28, 1998.
  
  
• Lecturer, Emerging treatments in Epilepsy
  The Chart House, Long Boat Key, Florida.
  August 26, 1998.
  
  
• Monotherapy Lamictal presented for Lamical Advisory Panel Meeting.
  Donatello's restaurant.
  September 28, 1998.
  
  
• Lecturer, Updates on Epilepsy Management
  Epicon Symposium, Sarasota, Florida.
  November 7, 1998.
  
  
• Lecturer, Roundtable discussion on Lamotrigene
  Le Bourdeau, Tampa, Florida
  December 2, 1998.
  
  
• Lecturer, Management of Epilepsy/Surgery & Seizures, Brain-A-Mania
  Sponsored by Epilepsy Services & Foundations of Tampa Bay and Sarasota
  January 23, 1999.
  
  
• Lecturer, New AED Formulations
  Michaels East, Sarasota, Florida
  January 27, 1999.
  
  
• Lecturer, Updates on Parenteral AED Formulations: a focus on IV Valproate
  Marriot Hotel
  February 23, 1999.
  
  
• Lecturer, Neuro-Psychiatric Spectrum of Epilepsy
  The Tampa Club
  March 3, 1999.
  
  
• Lecturer, Advances in Monotherapy for the Treatment of Epilepsy.
  Sponsored by Glaxo-Wellcome.
  DelFrisco's Steak and Seafood, Orlando, FL.
  August 24, 1999
  
  
• Lecturer, Acute Management of Seizures.
  Donatello’s, Tampa, FL
  October 12, 1999.
  
  
• Course Director/Lecturer, Epilepsy Patient Care: Into the New Millennium.
  Community Event. Tampa General Hospital, Tampa, FL.
  April 4, 2000.
  
  
• Lecturer, AED Treatment Update.
  Charlie’s Steakhouse. Tampa, FL.
  May 11, 2000.
  
  
• Lecturer, Expanding the Uses of Anti-Convulsants.
  Sponsored by Glaxo-Wellcome.
  Charlie’s Steakhouse. Tampa, FL
  August 17, 2000
  
  
• Lecturer, Depacon® as an IV AED Alternative.
  Neurology Consultant’s Meeting.
  Sponsored by Abbott Laboratories.
  Renaissance Vinoy Resort. St. Petersburg, FL.
  September 23, 2000
  
  
• Moderator/Facilitator, Southeast Regional Advisory Board Meeting.
  Sponsored by UCB Pharma, Inc.
  St. Petersburg, FL.
  March 31-April 1, 2001.
  
  
• Lecturer, Adverse Events Associated with VNS and VNS and Drug Reduction.
  Sponsored by Emory University. Supported by Cyberonics, Savannah, Georgia.
  
  
• Lecturer, Therapeutic Options for Managing Patients with Epilepsy.
  Sponsored by Shire US, Inc.
  Donatello’s, Tampa, FL.
  June 11, 2001.
  
  
• Lecturer, Intravenous Drug Therapy for Epilepsy and Seizures.
  Abbott Laboratories Neurology Consultants Meeting. Orlando, FL
  June 23, 2001.
  
  
• Lecturer, Intravenous Drug Therapies - New Options for Seizure Patients.
  Dinner Program for Emergency Room Physicians.
  Sponsored by Abbott Laboratories. Maggiano’s Restaurant.
  November 9, 2001.
  
  
• Lecturer, The Management of Acute Repetitive Seizures, Walking the Fine Line of Acute Seizure Management.
  Sponsored by Xcel Pharmaceuticals.
  St. Petersburg Times Forum. Tampa, FL.
  October 17, 2002
  
  
• Lecturer, Long-Term Management of Pharmacoresistant Epilepsy
  Wyndham Harbour Island Hotel, Tampa, FL
  February 8, 2003
  
  
• Local Host, Discovering Health in Epilepsy: An Exploration of Prognosis, Treatment, Behavior and Emotion.
  Hyatt Regency Tampa.
  May 29, 2003.
  
  
• Lecturer, Comparing AEDs.
  Sponsored by Ortho-McNeill Pharmaceuticals. Tampa, FL
  August 21, 2003.
  
  
• Lecturer, Long-Term Management of Pharmacoresistant Epilepsy.
  Sponsored by Cyberonics.
  Shula’s Steakhouse, Tampa, FL.
  November 12, 2003.
  
  
• Chair, Long-Term Management of Pharmacoresistant Epilepsy.
  Faculty included Bruno Gallo, MD, George Morris MD and E. Ramsay, MD.
  Sponsored by Cyberonics.
  JW Marriott Hotel, Miami, Florida.
  November 15, 2003.
  
  
• Lecturer, Round Table Discusion on Women with Epilepsy.
  Sponsored by UCB Pharma, Inc.
  Armani’s, Tampa, FL.
  March 5, 2004.
  
  
• Lecturer, Epilepsy Education Day.
  Sponsored by the Epilepsy Services of West Central Florida.
  University Community Hospital, Tampa FL.
  November 4, 2004.
  
  
• Roundtable Discussion, “Mood Disorders in Epilepsy”.
  Sponsored by Cyberonics.
  North Miami Beach, Florida
  9/29/05
  
  
• Roundtable Discussion, “Mood Disorders in Epilepsy”.
  Sponsored by Cyberonics.
  Shula’s Steak House
  Tampa, Florida
  10/26/2005
  
  
• Roundtable Discussion, “Case Presentations in Epilepsy”.
  Sponsored by UCB Pharma.
  Capitol Grill
  Tampa, Florida
  10/27/05
  
  
• Northside Mental Health, “The Psychiatric Profile of Epilepsy”.
  Sponsored by Glaxo-Smith-Kline.
  Tampa, Florida 12/7/05.
  
  
• Roundtable Discussion, “Mood Disorders in Epilepsy”.
  Sponsored by Cyberonics.
  Ruth Chris
  Winter Park, Florida, 12/7/05.
  
  
• Roundtable Discussion, “Topiramate Monotherapy”.
  Sponsored by Ortho-McNeil.
  Landry’s Steakhouse
  Tampa, Florida, 12/14/05.
  
  
• Lecturer, web-based interactive video conference: Updates on Women With Epilepsy.
  Sponsored by Eisai Inc. October 5, 2005.
  
  
• EEG, Epilepsy & Bedside EEG Monitoring: Advances in Clinical Practice.
  Sponsored by Morton Plant Mease Healthcare. Lectures on EEG Epilepsy Case Studies and Status Epilepticus.
  Clearwater, Florida 2/2-2/3/06.
  
  
• Managing Seizure Control, Lecturer, Epilepsy Education Day
  University Community Medical Center-Fletcher, Tampa, Florida, 2/21/06
  
  
• Evaluating Seizures, Lecturer,
  Hyde Park Community Education Series, Tampa General Hospital,
  Tampa, Florida 5/4/06.
  
  
• Emergent Treatment of Seizures
  Sponsored by UCB Pharma
  Capitol Grill, Tampa, Florida, 5/10/06.
  
  
• Epilepsy in the Elderly
  Sponsored by UCB Pharma for PharMerica
  The Palm Restaurant, Tampa, Florida, 5/31/06.
  
  
• Intravenous AED Use in the Emergency Department.
  Sponsored by UCB Pharma.
  Mease Safety Harbor Emergency Department. Safety Harbor, Florida. 9/6/06.
  
  
• IV AEDs in the hospital setting.
  Sponsored by UCB Pharma.
  Maison Carlos. West Palm Beach, Florida. 1/19/07.
  
  
• Women & Epilepsy: A one day community event.
  Sponsored by the EFA.
  “Managing reproductive health in women with epilepsy.
  Hilton Tampa Airport Westshore, Tampa, Florida. 1/27/07.
  
  

Return to Top

• Channel 8 - Tampa Bay Today regarding Epilepsy. November 13, 1991.
  
  
• Channel 8, Alive at Five (5 p.m. News) Regarding Epilepsy Conference At Tampa General Hospital. October 29, 1993.
  
  
• Channel 32 - Senior Connection. "Neurological Complications in the elderly." Kathy Beck and Bob Shank, co-hosts. August 23, 1994
  
  
• Channel 10 - Tampa General Hospital 11 p.m. News Re: Fatality from seizures at Busch Gardens Amusement Park, 1994.
  
  
• Channel 8 - 11:00 News, Highlights in Epilepsy. November 26, 1994.
  
  
• Newschannel 8 WFLA-TV (NBC). Epilepsy Treatment: Brain pacemaker for epilepsy patients. Revolutionary procedure. March 19, 1998
  
  
• 28 Tampa Bay News at 6. WFTS-TV (ABC). BRAIN Pacemaker. A new device is changing the lives of people with epilepsy; a look at some Tampa residents who are part of this medical first. March 19, 1998.
  
  
• 44 News At Ten WTOG-TV (UPN). Health Alert. Tampa General Hospital is implanting a revolutionary pacemaker to help epileptics. March 19, 1998.
  
  
• 10 News at Noon WTSP-TV (CBS). Revolutionary brain pacemakers. Doctors from Tampa General Hospital announced a revolutionary new procedure this morning to help pattients suffering from epilepsy. March 19, 1998.
  
  
• Daybreak at 6:00 WTSP-TV (CBS). Brain Pacemaker. Tampa General Hospital is implanting new pacemaker devices for epileptics. March 20, 1998.
  
  
• Press Conference, First VNS Implant Western Florida. Tampa, Florida. March 19, 1998.
  
  
• Interview ABC channel 28 (WFTS) “Medical Breakthroughs”-Epilepsy Seminar at TGH. September 19, 1999.
  
  
• Good Day Tampa Bay, FOX 13, Latest Treatments Available for Epilepsy, Treatment and Research. March 22, 2000.
  
  
• Interview, Epilepsy.com. Jenna Martin, Senior Editor. Case Management in Epilepsy: An Impact Study. New Orleans, LA. December 6, 2004.
  
  
• Epilepsy Management Teleconference Leader. Sponsored by Shire Pharmaceuticals. January 9, 2002 and January 16, 2002.
  
  
• Epilepsy Awareness interview with Jeff Butera on AM 850 in Gainesville, FL February 17, 2002.
  
  
• Was that a Seizure?
  Epilepsy Education Day sponsored by University Community Hospital. November 4, 2004.
  
  
• Web-based interactive video conference: Acute Seizure Emergencies.
  Sponsored by Valeant Pharmaceuticals.
  April 28, 2005.
• Lecturer, web-based interactive video conference: Updates on Women With Epilepsy.
  Sponsored by Eisai Inc.
  October 5, 2005.
• Interview for Charlotte Herald Tribune.
  Port Charlotte, Florida. Billy Cox. 12/21/06.

Return to Top

• "EEG/Record Review". Grand Rounds, University of South Florida with Dr. Brock. March 11, 1997
  
  
• "Post Traumatic Seizures" Grand Rounds, University of South Florida. April 1, 1997
  
  
• "Updates on Epilepsy". Grand Rounds, USF Family Practice at Tampa General Hospital, Tampa, Florida. August 14, 1997.
  
  
• "Treatment of Epilepsy in Mentally-Retarded/Multiple Handicapped". USF Neurology Grand Rounds, Tampa, Florida. November 20, 1997.
  
  
• Lecturer, "New Antiepileptic Drugs". Neurology Grand Rounds. Bay Pines VA Hospital. March 10, 1998.
  
  
• Presurgical Evaluation of Epilepsy. Neurosurgery Grand Rounds, University of South Florida. Tampa General Hospital. March 20, 1998
  
  
• Neurology Grand Rounds, "Epilepsy and multiple handicapped: New Anti-epileptic Drugs". Bay Pines VA Hospital. March 10, 1998.
  
  
• Neurosurgery Grand Rounds, Presurgical Evaluation of Epilepsy. University of South Florida. March 30, 1998.
  
  
• Lecture series, EEG Course for Residents. University of South Florida, MDC 1097. Tampa, Florida. April 15, 1998. Normal EEG Physiology. May 27, 1998. EEG Tech Electronics localization and polarity.
  
  
• Lecturer, EEG in status epilepticus. Neurology Grand Rounds. Tampa General Hospital, University of South Florida College of Medicine. July 23, 1998.
  
  
• Lecturer, "Neurosurgical application of the new AEDs". Neurosurgery Grand Rounds, University of South Florida. Tampa General Hospital. October 27, 1998.
  
  
• Lecturer, "A Review of Neurology/Dermatology for the Primary Care Provider". Sand Key, Florida. May 8-9, 1999
  
  
• Co-Course Director and Lecturer, "Neurology in the New Millennium": Neuropsychiatric Spectrum of Epilepsy, Women & Epilepsy, New Anti-Epileptic Drugs, Seizures and Spells, Treatment of Acute Stroke, Dementia, Parasomnias and Sleep Disorders, Painful Neuropathies, Status Epilepticus and Acute Seizure Management. Alaska Cruise, ms Nieuw Amsterdam. June 17-24, 1999.
  
  
• Lecturer, Primary Care Update on Aging. Sponsored by the University of South Florida College of Medicine. Sheraton Sand Key Resort, Clearwater, FL. August 14-15, 1999.
  
  
• Lecturer, Women and Epilepsy, Neurology Grand Rounds. University of South Florida. Tampa General Hospital. September 2, 1999.
  
  
• Lecturer, New Drugs and Devices, Sponsored by the University of South Florida Office of Continuing Medical Education. SideBern’s. Tampa, FL. November 18, 1999.
  
  
• Lecturer, Post Traumatic Epilepsy. Brain Injury. Co-sponsored by the University of South Florida Office of Continuing Education and the Florida Institute for Neurologic Rehabilitation. Embassy Suites, Tampa, FL. April 15, 2000.
  
  
• Co-course director and lecturer, 2nd Annual “Neurology in the New Millennium” Neuropsychiatric Spectrum of Epilepsy, Women & Epilepsy, New Anti-Epileptic Drugs, Seizures and Spells, Treatment of Acute Stroke, Dementia, Parasomnias and Sleep Disorders, Painful Neuropathies, Status Epilepticus and Acute Seizure Management. Lecturers: Peter B Dunne, MD and William O. Tatum, IV DO Scandinavia and Russia. July 2-9, 2000.
  
  
• Course Director, William O. Tatum, IV Clinical Neurophysiology: A Practice Based Approach. Speakers Erasmo Passaro, R. Eugene Ramsay, Rodney A. Radtke, Prassana Jayakar and Robin Gilmore.
  
  
• Lecturer, Long-Term EEG Monitoring. February 17, 2001. Sponsored by USF College of Medicine. St Petersburg Beach, FL
  
  
• Co-Course Director and lecturer, 3rd Annual “Neurology in the New Millennium” Neuropsychiatric Spectrum of Epilepsy, Women & Epilepsy, New Anti-Epileptic Drugs, Seizures and Spells, Treatment of Acute Stroke, Dementia, Parasomnias and Sleep Disorders, Painful Neuropathies, Status Epilepticus and Acute Seizure Management. Lecturers: Peter B Dunne, MD and William O. Tatum, IV DO Panama Canal. March 19-29, 2001.
  
  
• Lecturer, Women and Epilepsy: Special Issues, part of “Advances in Epilepsy”sponsored by the University of South Florida CME office. Orlando, FL. April 7, 2001.
  
  
• Lecturer, Post Traumatic Epilepsy and Ictal Violence, part of the “Traumatic Brain Injury II” sponsored by the University of South Florida CME. Key West, Florida. May 19-20, 2001.
  
  
• ACCME Self-Study Oversight Committee, Clinical Faculty. John Curran M.D., Committee Chairman 2001
  
  
• Course Director, A Focus on Anti-epileptic Drugs and Devices. Part “Updates in Clinical Psychiatry” Course. Tampa Marriott Waterside Hotel. October 13, 2001.
  
  
• Lecturer/Panelist, Epilepsy Awareness Month. Jointly sponsored by the Tampa General Hospital Comprehensive Epilepsy Program and the University of South Florida. November 15, 2001. Tampa General Hospital
  
  
• Lecturer, The Medical Treatment of Epilepsy. Part of “Neurology in the New Millennium” Sponsored by the University of South Florida College of Medicine. Hyatt Regency Westshore, Tampa, Florida. April 13, 2002.
  
  
• Lecturer, The Ins and Outs of Seizures and What to Know About Peripheral Neuropathy Part of the One Brain Many Disorders: A Neurology Review for Primary Care Medicine. Sponsored by the University of South Florida. Hawk’s Cay Resort and Marina. Duck Key, Florida. May 10-12, 2002.
  
  
• Lecturer, “Interictal Abnormalities and Normal Variants”. Part of Clinical EEG and Epilepsy Monitoring: A Practical Review. Sponsored by the University of South Florida and Tampa General Hospital. Hyatt Regency, Tampa, Florida. August 3, 2002.
  
  
• Lecturer, Anti-Convulsant Use in Clinical Psychiatry. Part of Second Annual Updates in Clinical Psychiatry: A Focus on Anti-Epileptic Drugs. Sponsored by the University of South Florida. Disney’s Grand Floridian Resort. September 14, 2002.
  
  
• Lecturer, Dementia, Women and Epilepsy, Status Epilepticus, Electrical Stimulation of the CNS, Peripheral Neuropathy, Treatment of Acute Stroke, Seizures and Spells, Brain Trauma, Seizures and Violence. Sponsored by the University of South Florida. The University at Sea. Western Caribbean ms. Massdam. November 24-December 1, 2002.
  
  
• Lecturer, Seizures and Epilepsy, Updates on Antiepileptic Drugs, Long-term EEG monitoring, Addressing Status Epilepticus, Women and Epilepsy, The Neurosurgical Treatment of Epilepsy and Case Studies in Epilepsy. Part of the “Update in Neurology with a focus on Epilepsy and Pain” Cruise Conference. Sponsored by the University of South Florida. The University at Sea. Hawaiian Cruise. Norwegian Star. February 23-March 2, 2003.
  
  
• Participant, Patient presentation: Seizure vs. Syncope. Dr. Doug Schocken. LCE Large Group Conference. HSC Auditorium March 13, 2003.
  
  
• Lecturer, Pharmacotherapy for Epilepsy. Part of the Neurology in the New Millennium Course. Sponsored by the University of South Florida College of Medicine. Hyatt Regency Tampa. April 26, 2003.
  
  
• Participant, LCE (Longitudinal Clinical Experience) Program, University of South Florida College of Medicine. 2002-2003.
  
  
• Lecturer, Epileptic Aura. The Brain Club, University of South Florida College of Medicine. May 16, 2003.
  
  
• Lecturer, Casting the Diagnosis on Spells, Anticonvulsants and Psychiatric Disorders, Managing Epilepsy in the New Millenium, and VNS, Neurosurgery and Psychiatry. Part of the Keys to Neuropsychiatric Case” Sponsored by the University of South Florida. Hawk’s Cay Resort and Marina Florida. September 5-7, 2003.
  
  
• Neurology Grand Rounds, Advanced Practices for Women with Epilepsy. Tampa General Hospital. September 18, 2003.
  
  
• Lecturer, Neuropathy: The Treatable Ones, Epilepsy in the New Millennium, Acute Seizure Emergencies, Viewing Spells of Significance, Ischemic Cerebral Vascular Disease and Community Standards, Women and Seizure Disorders, Alzheimer’s Disease: A Growing Epidemic and Boy Have I Got A Case for You. Sponsored by the University of South Florida. The University at Sea. Italian Cruise. October 20 - October 25, 2003.
  
  
• Lecturer, Herpes Zoster Opthalmicus with Delayed Contralateral Hemiparesis. LCE Presentation. Program Director Dr. Richard Hoffman. University of South Florida. January 14, 2004.
  
  
• Lecturer, Updates on the Treatment of Epilepsy in Women. Part of the 2nd Annual Spring Symposium for Nurse Practioners co-sponsored by the University of South Florida College of Nursing, Tampa Bay Advance Practice Nurses’ Council and the Florida Network of Nurse Practitioners. University of South Florida. March 19, 2004.
  
  
• Lecturer, Epilepsy: Matching the Medicine to the Patient. Neurology in the New Millennium Symposium. Sponsored by the University of South Florida and Tampa General Hospital. Hyatt Regency Tampa. October 30, 2004.
  
  
• Lecturer, Updates on Epilepsy. Heart-to-Heart, Linking Body, Mind and Spirit. Cheryl Reed, Course Director. Co-Sponsored by the University of South Florida. Wesley Chapel, FL. February 25, 2005.
  
  
• Lecturer, “Vagus Nerve Stimulation: The Epilepsy Experience”. A Long-Term Strategy for Treatment-Resistant Depression. Chair Dr. Francisco Fernandez, USF Department of Psychiatry. Sponsors: Cyberonics. Grand Hyatt Tampa Bay, Tampa, Florida 9/23-24/05.
  
  
• Resident Meeting, Dr. Benbadis-Tatum, Updates from AES 2005-Abstract presentations, 12/05, Jackson’s restaurant, Tampa, FL.
  
  
• Lecturer, A Focused Approach to Treatment. Neurology in the New Millennium Symposium. Sponsored by the University of South Florida and Tampa General Hospital. Embassy Suites Hotel Tampa, FL. February 11, 2006. Dr. Robert A. Hauser MD, MBA-course director.
  
  
• Course Director and Lecturer, Neurology Review 2006: Emergency Treatment of stroke, Dementia, Seizures, Epilepsy, Case Studies, Neurology images: What is it?, Approach to peripheral neuropathy. Cas Cahill, ARNP co-director USF College of Nursing. Eastern Carribean 4/8-4/15/06.
• Lecturer, Women and Epilepsy: a focus on the child-bearing years. Presentation to the resident neurology house staff.
  Jackson’s Bistro. Tampa, Florida.
  Sponsored by UCB Pharma. 8/31/06.
• Lecturer, The EEG and Psychiatry.
  Presentation to the psychiatry senior residents.
  Psychiatry center USF. 1/25/07.
• Course Director and Lecturer, Neurology Review 2007: Acute Brain Attack, Updates on Dementia of the Alzheimer Type, Seizures, Epilepsy Management, Case Studies in Neurology, What is it?: a pictorial approach to neurologic diagnosis, Diabetic eripheral neuropathy.
  Stan Krolczyk DO, RPh., assistant professor USF Department of Neurology.
  Mexican Riviera 3/24/07-3/31/07.
• Lecturer, The Medical Treatment of Epilepsy. Neurology in the New Millennium Symposium.
  Sponsored by the University of South Florida and Tampa General Hospital.
  Tampa Bay Performing Arts Tampa, FL. September 15, 2007.
  Dr. Robert A. Hauser MD, MBA-course director.

Return to Top

• Lamotrigine in patients with AIDS-related painful peripheral neuropathy. Sponsored by Glaxo-Wellcome. Proposed award $32,000 (closed) Principal Investigator 1997-1998.
  
  
• Open Label Post Marketing Study of AED Reduction using VNS in Adults. Sponsored by Cyberonics. Award $16,000 Principal investigator. 1998-9.
  
  
• Cost Analysis of Diazepam Rectal Gel Use in Institutionalized Epilepsy Patients. Sponsored by Elan Pharma. Award $3,000. Principal Investigator. 2000.
  
  
• Patient Perception of the Use of Rectal Medications in Patients with Epilepsy. Sponsored by Elan Pharma. Award $2,800. Principal Investigator. 2001.
  
  
• Evaluation of the Florida Intergrated Case Management Intervention Program on Treatment Outcomes and Quality of Life of Medically Indigent Patients with Epilepsy. Sponsored by the University of South Florida. Principal investigator- Susan Kelley, PhD. Award $15,500. 2001. Co-Principal Investigator Neal Berger, Ph.D. and William O. Tatum, IV, DO.
  

Return to Top